Ann: Emyria Appoints Expert Neuropharmacologist for MDMA Program, page-3

  1. 108 Posts.
    lightbulb Created with Sketch. 64
    The New Scientist publised an article in 2002 about the beneficial effects of MDMA in Parkinson's. These MDMA analouges could be ever better without the side effect of getting high.
    https://www.newscientist.com/article/dn3015-ecstasy-has-dramatic-effect-on-parkinsons-symptoms/

    Also, the famous Prof David Nutt spoke about these UWA researchers in an article from 2013. There is some interesting insight there on why more research has not been done on these promising compounds.

    https://theconversation.com/david-nutt-i-was-sacked-i-was-angry-i-was-right-19848
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
3.5¢
Change
0.001(2.94%)
Mkt cap ! $21.40M
Open High Low Value Volume
3.4¢ 3.5¢ 3.1¢ $221.0K 6.502M

Buyers (Bids)

No. Vol. Price($)
1 400000 3.4¢
 

Sellers (Offers)

Price($) Vol. No.
3.5¢ 392668 1
View Market Depth
Last trade - 16.11pm 18/07/2025 (20 minute delay) ?
EMD (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.